Senzime AB (publ) (SEZI.ST)
SEZI.ST Stock Price Chart
Explore Senzime AB (publ) interactive price chart. Choose custom timeframes to analyze SEZI.ST price movements and trends.
SEZI.ST Company Profile
Discover essential business fundamentals and corporate details for Senzime AB (publ) (SEZI.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
18 Jun 2008
Employees
54.00
Website
https://senzime.comCEO
Philip Siberg
Description
Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode array, which has two proximal stimulating electrodes for recording and reference; TetraConnect, a data management portal that helps clinician to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor. It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and Onzurf Probe, a sterile CE-marked single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver. Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records. The company was incorporated in 1999 and is based in Uppsala, Sweden.
SEZI.ST Financial Timeline
Browse a chronological timeline of Senzime AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 20 Apr 2026
Upcoming earnings on 16 Feb 2026
Upcoming earnings on 4 Nov 2025
Earnings released on 18 Jul 2025
EPS came in at -kr 0.24 falling short of the estimated -kr 0.17 by -43.58%, while revenue for the quarter reached kr 25.70M , beating expectations by +3.19%.
Earnings released on 22 Apr 2025
EPS came in at -kr 0.27 falling short of the estimated -kr 0.24 by -12.50%, while revenue for the quarter reached kr 23.50M , missing expectations by -4.09%.
Earnings released on 13 Feb 2025
EPS came in at -kr 0.20 falling short of the estimated -kr 0.20 by -0.16%, while revenue for the quarter reached kr 14.03M , missing expectations by -22.03%.
Earnings released on 6 Nov 2024
EPS came in at -kr 0.26 falling short of the estimated -kr 0.20 by -30.00%, while revenue for the quarter reached kr 17.41M , missing expectations by -43.85%.
Earnings released on 26 Aug 2024
EPS came in at -kr 0.28 falling short of the estimated -kr 0.20 by -40.00%, while revenue for the quarter reached kr 14.92M , missing expectations by -25.42%.
Earnings released on 7 May 2024
EPS came in at -kr 0.23 surpassing the estimated -kr 0.30 by +23.33%, while revenue for the quarter reached kr 12.12M , missing expectations by -39.40%.
Earnings released on 15 Feb 2024
EPS came in at -kr 0.33 falling short of the estimated -kr 0.30 by -10.00%, while revenue for the quarter reached kr 10.85M , missing expectations by -16.54%.
Earnings released on 26 Oct 2023
EPS came in at -kr 0.33 falling short of the estimated -kr 0.30 by -10.00%, while revenue for the quarter reached kr 9.15M , missing expectations by -16.78%.
Earnings released on 24 Aug 2023
EPS came in at -kr 0.42 falling short of the estimated -kr 0.33 by -27.27%, while revenue for the quarter reached kr 8.46M , beating expectations by +20.89%.
Earnings released on 28 Apr 2023
EPS came in at -kr 0.42 , while revenue for the quarter reached kr 7.29M , beating expectations by +30.14%.
Stock split effective on 16 Feb 2023
Shares were split 1013 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 Feb 2023
EPS came in at -kr 0.28 , while revenue for the quarter reached kr 4.55M .
Earnings released on 10 Nov 2022
EPS came in at -kr 0.73 , while revenue for the quarter reached kr 3.72M .
Earnings released on 15 Jul 2022
EPS came in at -kr 0.62 , while revenue for the quarter reached kr 3.40M .
Earnings released on 5 May 2022
EPS came in at -kr 0.32 , while revenue for the quarter reached kr 2.36M .
Earnings released on 17 Feb 2022
EPS came in at -kr 0.30 , while revenue for the quarter reached kr 3.72M .
Earnings released on 12 Nov 2021
EPS came in at -kr 0.30 , while revenue for the quarter reached kr 1.44M .
Earnings released on 27 Aug 2021
EPS came in at -kr 0.35 , while revenue for the quarter reached kr 4.39M .
Earnings released on 6 May 2021
EPS came in at -kr 0.27 , while revenue for the quarter reached kr 1.44M .
Earnings released on 26 Feb 2021
EPS came in at -kr 0.26 , while revenue for the quarter reached kr 3.49M .
Earnings released on 6 Nov 2020
EPS came in at -kr 0.19 , while revenue for the quarter reached kr 2.10M .
SEZI.ST Stock Performance
Access detailed SEZI.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.